Responses
Clinical science
Original article
Combination therapy with low-dose transpupillary thermotherapy and intravitreal ranibizumab for neovascular age-related macular degeneration: a 24-month prospective randomised clinical study
Compose a Response to This Article
Other responses
No responses have been published for this article.